Product Information
LAMOTRIGINE ODT 200 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.4657 per EA under NDC 00115994201. Its NADAC has been published 72 times since Apr 9, 2025.
FDA first approved this application on Jul 15, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115994201
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA200828FDA Approved
7/15/2013
TE Code
AB
On Market Since
12/27/2018
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ODT 200 MG TABLET has been published 72 times since Apr 9, 2025, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4657 per EA |
|---|---|
| All-time high | $3.3589 (Jun 11, 2025) |
| All-time low | $1.3404 (Jul 22, 2026) |
| 52-week high | $2.5962 |
| 52-week low | $1.3404 |
| Median price | $2.3658 |
| Average price | $2.3201 |
| Largest weekly change | -15.3% (Apr 22, 2026) |
| Weeks tracked | 72 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ODT 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 200 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.4657 per EA (NDC 00115994201), effective Aug 19, 2026.
How has the price of LAMOTRIGINE ODT 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ODT 200 MG TABLET has declined 47.2%. It has been tracked across 72 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 200 MG TABLET?
Since Apr 9, 2025, the NADAC for LAMOTRIGINE ODT 200 MG TABLET has ranged from a low of $1.3404 (Jul 22, 2026) to a high of $3.3589 (Jun 11, 2025), with a median of $2.3658 per EA.
Are there cheaper alternatives to LAMOTRIGINE ODT 200 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUBVENITE 200 MG TABLET, is $0.0840 per EA — about 94% below LAMOTRIGINE ODT 200 MG TABLET.
Who manufactures LAMOTRIGINE ODT 200 MG TABLET?
LAMOTRIGINE ODT 200 MG TABLET (NDC 00115994201) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.